Manganese-enhanced magnetic resonance imaging (MEMRI) of mouse brain development

Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA.
NMR in Biomedicine (Impact Factor: 3.56). 11/2004; 17(8):613-9. DOI: 10.1002/nbm.932
Source: PubMed

ABSTRACT Given the importance of genetically modified mice in studies of mammalian brain development and human congenital brain diseases, MRI has the potential to provide an efficient in vivo approach for analyzing mutant phenotypes in the early postnatal mouse brain. The combination of reduced tissue contrast at the high magnetic fields required for mice, and the changing cellular composition of the developing mouse brain make it difficult to optimize MRI contrast in neonatal mouse imaging. We have explored an easily implemented approach for contrast-enhanced imaging, using systemically administered manganese (Mn) to reveal fine anatomical detail in T1-weighted MR images of neonatal mouse brains. In particular, we demonstrate the utility of this Mn-enhanced MRI (MEMRI) method for analyzing early postnatal patterning of the mouse cerebellum. Through comparisons with matched histological sections, we further show that MEMRI enhancement correlates qualitatively with granule cell density in the developing cerebellum, suggesting that the cerebellar enhancement is due to uptake of Mn in the granule neurons. Finally, variable cerebellar defects in mice with a conditional mutation in the Gbx2 gene were analyzed with MEMRI to demonstrate the utility of this method for mutant mouse phenotyping. Taken together, our results indicate that MEMRI provides an efficient and powerful in vivo method for analyzing neonatal brain development in normal and genetically engineered mice.

Download full-text


Available from: Youssef Zaim Wadghiri, Jul 30, 2015
  • Source
    • "In vivo MEMRI Allowed Noninvasive Detection of MB Tumors in Ptch1-CKO Mice As demonstrated previously [49] [53], in vivo MEMRI images showed region-specific signal and contrast enhancement in the mouse brain and allowed more detailed visualization of normal Cb morphology when compared to a non-MEMRI image (Figure 1, A and B). Abnormal Cb lesions were detected and easily delineated as hypointense regions within the enhanced Cb (Figure 1, C–E) in 74 of 92 Ptch1-CKO mice imaged with MEMRI between 11 and 28 weeks of age (80%). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mouse models have increased our understanding of the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor that often forms in the cerebellum. A major goal of ongoing research is to better understand the early stages of tumorigenesis and to establish the genetic and environmental changes that underlie MB initiation and growth. However, studies of MB progression in mouse models are difficult due to the heterogeneity of tumor onset times and growth patterns and the lack of clinical symptoms at early stages. Magnetic resonance imaging (MRI) is critical for noninvasive, longitudinal, three-dimensional (3D) brain tumor imaging in the clinic but is limited in resolution and sensitivity for imaging early MBs in mice. In this study, high-resolution (100 μm in 2 hours) and high-throughput (150 μm in 15 minutes) manganese-enhanced MRI (MEMRI) protocols were optimized for early detection and monitoring of MBs in a Patched-1 (Ptch1) conditional knockout (CKO) model. The high tissue contrast obtained with MEMRI revealed detailed cerebellar morphology and enabled detection of MBs over a wide range of stages including pretumoral lesions as early as 2 to 3 weeks postnatal with volumes close to 0.1 mm(3). Furthermore, longitudinal MEMRI allowed noninvasive monitoring of tumors and demonstrated that lesions within and between individuals have different tumorigenic potentials. 3D volumetric studies allowed quantitative analysis of MB tumor morphology and growth rates in individual Ptch1-CKO mice. These results show that MEMRI provides a powerful method for early in vivo detection and longitudinal imaging of MB progression in the mouse brain.
    Neoplasia (New York, N.Y.) 12/2014; 16(12):993. DOI:10.1016/j.neo.2014.10.001 · 5.40 Impact Factor
  • Source
    • "Longitudinal growth maps through several time points can provide a quantitative picture of the growth process from birth through adulthood. Comparisons of in vivo images of neonatal mice with different genotypes have also demonstrated potential for phenotyping, visualizing, for instance, abnormalities in the Gbx2 mutant cerebellum (Fig. 21.5; Wadghiri et al., 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ultrasound biomicroscopy (UBM) and magnetic resonance microimaging (micro-MRI) provide noninvasive, high-resolution images in mouse embryos and neonates, enabling volumetric and functional analyses of phenotypes, including longitudinal imaging of individual mice over critical stages of in utero and early-postnatal development. In this chapter, we describe the underlying principles of UBM and micro-MRI, including the advantages and limitations of these approaches for studies of mouse development, and providing a number of examples to illustrate their use. To date, most imaging studies have focused on the developing nervous and cardiovascular systems, which are also reflected in the examples shown in this chapter, but we also discuss the future application of these methods to other organ systems.
    Methods in enzymology 01/2010; 476:379-400. DOI:10.1016/S0076-6879(10)76021-3 · 2.19 Impact Factor
  • Source
    • "Jack et al. (2004) used a 9.4-T scanner and customized radiofrequency coil specific for imaging murine brain. The ability to directly visualize b-amyloid plaques using MRI is thought to be due to time-related iron accumulation (Jack et al., 2004; Wadghiri et al., 2004; Vanhoutte et al., 2005). MRI is sensitive to these iron accumulations due to T 2 and T 2 Ã susceptibility effects that they cause, effectively spoiling the MR signal normally attained from the brain parenchyma . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Two significant barriers have limited the development of effective treatment of Alzheimer's disease. First, for many cases the aetiology is unknown and likely multi-factorial. Among these factors, hypercholesterolemia is a known risk predictor and has been linked to the formation of beta-amyloid plaques, a pathological hallmark this disease. Second, standardized diagnostic tools are unable to definitively diagnose this disease prior to death; hence new diagnostic tools are urgently needed. Magnetic resonance imaging (MRI) using high field-strength scanners has shown promise for direct visualization of beta-amyloid plaques, allowing in vivo longitudinal tracking of disease progression in mouse models. Here, we present a new rabbit model for studying the relationship between cholesterol and Alzheimer's disease development and new tools for direct visualization of beta-amyloid plaques using clinical field-strength MRI. New Zealand white rabbits were fed either a low-level (0.125-0.25% w/w) cholesterol diet (n = 5) or normal chow (n = 4) for 27 months. High-resolution (66 x 66 x 100 microm(3); scan time = 96 min) ex vivo MRI of brains was performed using a 3-Tesla (T) MR scanner interfaced with customized gradient and radiofrequency coils. Beta-amyloid-42 immunostaining and Prussian blue iron staining were performed on brain sections and MR and histological images were manually registered. MRI revealed distinct signal voids throughout the brains of cholesterol-fed rabbits, whereas minimal voids were seen in control rabbit brains. These voids corresponded directly to small clusters of extracellular beta-amyloid-positive plaques, which were consistently identified as iron-loaded (the presumed source of MR contrast). Plaques were typically located in the hippocampus, parahippocampal gyrus, striatum, hypothalamus and thalamus. Quantitative analysis of the number of histologically positive beta-amyloid plaques (P < 0.0001) and MR-positive signal voids (P < 0.05) found in cholesterol-fed and control rabbit brains corroborated our qualitative observations. In conclusion, long-term, low-level cholesterol feeding was sufficient to promote the formation of extracellular beta-amyloid plaque formation in rabbits, supporting the integral role of cholesterol in the aetiology of Alzheimer's disease. We also present the first evidence that MRI is capable of detecting iron-associated beta-amyloid plaques in a rabbit model of Alzheimer's disease and have advanced the sensitivity of MRI for plaque detection to a new level, allowing clinical field-strength scanners to be employed. We believe extension of these technologies to an in vivo setting in rabbits is feasible and that our results support future work exploring the role of MRI as a leading imaging tool for this debilitating and life-threatening disease.
    Brain 03/2009; 132(Pt 5):1346-54. DOI:10.1093/brain/awp031 · 10.23 Impact Factor
Show more